Skip to NavigationSkip to content

Galecto hires new Chief Medical Officer

Published on: 07/02/20

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.

Lindmark joins from the eTheRNA immunotherapies, which is a Belgian mRNA immunotherapy company. He has also had an extensive and successful career in the pharmaceutical industry.

Hans Schambye, the Chief Executive Officer of Galecto, said: “We are very please to welcome Bertil to Galecto. His global background, deep scientific knowledge and leadership experience will further strengthen our ambitious targets as we progress GB0139 towards market and explore the potential of our exciting pipeline following the merger with PharmAkea.”

Lindmark was the Global Vice President of Clinical Development for the Respiratory and Inflammation franchises at AstraZeneca. It was here he led the development of Symbicort along with many other gastro-intestinal products. From 2010, he headed Research and Development at Almirall before joining ASLAN pharmaceuticals in Singapore where he focused on atopic skin and lung diseases as well as cancer.

In response to his appointment, Lindmark said: “I look forward to joining Galecto at such an important point in the company’s development. Galecto has a very promising combination of small molecule drug candidates in its pipeline: two targeting the role of galectin-3 in inhibiting cells involved in fibrosis, and one that inhibits LOXL2, a key enzyme involved in the formation of the extracellular matrix during the fibrotic process. These differentiated molecules in clinical phase form a strong foundation on which we aim to build a future global operation.”

Lindmark’s educational background is in medicine and gastroenterology and he obtained a PhD in molecular epidemiology from Lund University in Sweden. He was appointed a visiting professor at Gothenburg University for Innovation and Entrepreneurship at the Institute of Medicine.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches